bucladesine and Huntington Disease

bucladesine has been researched along with Huntington Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cuddon, P; Fleming, A; Floto, RA; Goldsmith, P; Jahreiss, L; O'Kane, CJ; Pask, D; Rubinsztein, DC; Saiki, S; Sarkar, S; Siddiqi, FH; Ttofi, EK; Williams, A1
El-Akabawy, G; Jeffries, A; Medina, LM; Modo, M; Price, J1

Other Studies

2 other study(ies) available for bucladesine and Huntington Disease

ArticleYear
Novel targets for Huntington's disease in an mTOR-independent autophagy pathway.
    Nature chemical biology, 2008, Volume: 4, Issue:5

    Topics: Animals; Autophagy; Calcium Channels, L-Type; Clonidine; Cyclic AMP; Humans; Huntington Disease; Imidazoline Receptors; Minoxidil; Protein Kinases; Signal Transduction; TOR Serine-Threonine Kinases; Type C Phospholipases; Verapamil

2008
Purmorphamine increases DARPP-32 differentiation in human striatal neural stem cells through the Hedgehog pathway.
    Stem cells and development, 2011, Volume: 20, Issue:11

    Topics: Antigens, Differentiation; Brain; Brain-Derived Neurotrophic Factor; Bucladesine; Calbindin 2; Calbindins; Cell Differentiation; Cell Line; Cell Proliferation; Cell Survival; Dopamine and cAMP-Regulated Phosphoprotein 32; Hedgehog Proteins; Humans; Huntington Disease; Interneurons; Morpholines; Neural Stem Cells; Purines; S100 Calcium Binding Protein G; Signal Transduction; Transcription Factors; Tretinoin; Up-Regulation; Valproic Acid; Zinc Finger Protein GLI1

2011